Advertisement

Picture BIO Deutschland German Corona Special 2021 Digital 650x80px
All >

News > Financings

Find below news about investments, acquisitions credits, grants in Europe and Israel or including organisations from these regions.

Total search results: 2442 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
DiaSorin S.p.A.. (4/11/21). "Press Release: DiaSorin to Acquire Luminex Corporation for USD 37.00 per Share or Approximately USD 1.8 Billion". Saluggia. 2021-04-11
Hologic, Inc.. (4/8/21). "Press Release: Hologic to Acquire Mobidiag, Innovator in Near-Patient, Acute Care Diagnostic Testing, for Approximately $795 Million". Marlborough, MA. 2021-04-08
Delta 4 GmbH. (4/7/21). "Press Release: Delta 4 Announces Closing of Multi-million Series A Financing Round". Vienna. 2021-04-07
Metagenomi Inc.. (4/7/21). "Press Release: Metagenomi Extends Series A Financing from RA Capital and Welcomes Andrew Levin to Its Board of Directors". Emeryville, CA. 2021-04-07
Metrion Biosciences Ltd.. (4/6/21). "Press Release: Metrion Biosciences Closes £2.7m New Equity Financing. Financing Led by Gresham House Ventures". Cambridge. 2021-04-06
Achilles Therapeutics plc. (4/6/21). "Press Release: Achilles Therapeutics Announces Closing of $175.5 Million Initial Public Offering". London. 2021-04-06
Drägerwerk AG & Co. KGaA. (4/1/21). "Press Release: Dräger Acquires Majority Share of Swiss Medical Technology Start-up STIMIT". Lübeck. 2021-04-01
Rentschler Biopharma SE. (3/31/21). "Press Release: Rentschler Biopharma Appoints Dr. Martin Kessler as Chief Executive Officer of U.S. Subsidiary and as Senior Vice President Transformation". Laupheim & Milford, MA. 2021-03-31
Achilles Therapeutics plc. (3/30/21). "Press Release: Achilles Therapeutics Announces Pricing of Initial Public Offering". London. 2021-03-30
Pyxis Oncology. (3/30/21). "Press Release: Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics". Cambridge, MA. 2021-03-30
Inbrain Neuroelectronics S.L.. (3/26/21). "Press Release: Inbrain Neuroelectronics Raises Over €14M Series A". Barcelona. 2021-03-26
Eliem Therapeutics, Inc.. (3/25/21). "Press Release: Eliem Therapeutics Emerges from Stealth with $80 Million Invested to Progress Multiple Clinical Stage Assets Targeting Neuronal Excitability Disorders". Seattle, WA & Cambrigde. 2021-03-25
Leyden Laboratories B.V.. (3/25/21). "Press Release: Leyden Labs to Unlock a New Generation of Preventative Medicines against Known and Future Viruses by Securing a €40 Million Series A from GV (formerly Google Ventures), F-Prime and Casdin Capital". Ams 2021-03-25
Immunai. (3/25/21). "Press Release: Immunai Acquires Dropprint Genomics and Strengthens Leadership Team with Experts in Immunology to Expand Target Discovery Capabilities". New York, NY. 2021-03-25
Immuneering Corporation. (3/25/21). "Press Release: Immuneering Expands Leadership Team with Appointment of Carolina Garcia Rizo, Ph.D., MBA, as Chief Business Officer". Cambridge, MA. 2021-03-25
Step Pharma S.A.S.. (3/24/21). "Press Release: Step Pharma Raises EUR35 Million in Series B Financing to Advance First in Class CTPS1 inhibitor into the Clinic in T Cell Malignancies". Archamps. 2021-03-24
PhoreMost Ltd.. (3/23/21). "Press Release: PhoreMost Closes £33M ($46M) Series B Financing". Cambridge. 2021-03-23
Dunad Therapeutics. (3/23/21). "Press Release: Dunad Therapeutics Emerges to Develop Next-generation Small Molecule Therapeutics Based on First Tuneable Targeted Protein Degradation Technology". Cambridge. 2021-03-23
Meatable. (3/23/21). "Press Release: Meatable Raises $47 Million Series A to Continue Scaling Trajectory and Expand its Product Portfolio with Beef". 2021-03-23
Auro Biosciences, Inc.. (3/22/21). "Press Release: Aura Biosciences Announces Oversubscribed $80 Million Financing". Cambridge, MA. 2021-03-22
Dotmatics Ltd.. (3/22/21). "Press Release: Insightful Science Joins Forces with Dotmatics to Form a Leading Cloud-First Scientific R&D Company". Bishop’s Stortford & San Diego, CA. 2021-03-22
Amphista Therapeutics Ltd.. (3/17/21). "Press Release: Amphista Therapeutics Raises $53M in Oversubscribed Series B Round to Advance Next Generation Targeted Protein Degradation Assets". Glasgow. 2021-03-17
ExeVir Bio B.V.. (3/16/21). "Press Release: ExeVir Announces Close of $50 Million / EUR42 million Series A Financing". Belgium. 2021-03-16
Alchemab Therapeutics Ltd.. (3/16/21). "Press Release: Alchemab and Medicines Discovery Catapult to Develop Landmark Novel Antibody Therapy for Huntington’s disease". London. 2021-03-16
CytoSeek Ltd.. (3/16/21). "Press Release: CytoSeek Raises £3.57M ($5M) to Advance Its Mission to Develop the Next Generation of Cell Therapies for Cancer". Bristol. 2021-03-16
Roche. (3/15/21). "Press Release: Roche Signs Definitive Merger Agreement with GenMark Diagnostics, Inc., to Access Novel Technology to Test for Broad Range of Pathogens with One Patient Sample". Basel. 2021-03-15
Cellink AB. (3/12/21). "Press Release: Cellink AB (publ) Announces the Completion of the Offering of Senior Unsecured Convertible Bonds Convertible into Class B Shares and a Class B Share Issue in an Overall Amount of SEK 3.0 Billion [NOT FOR US, CA, AU, 2021-03-12
Monte Rosa Therapeutics. (3/12/21). "Press Release: Monte Rosa Therapeutics Announces $95 Million Series C Financing to Accelerate Next-generation Protein Degradation Platform". Boston, MA. 2021-03-12
Touchlight Genetics Ltd.. (3/11/21). "Press Release: Touchlight Raises £42 Million ($58 Million) to Meet Unprecedented Global DNA Demand". Hampton. 2021-03-11
Cellink AB. (3/11/21). "Press Release: Cellink AB Announces an Offering of Senior Unsecured Convertible Bonds Convertible into Class B Shares and a Class B Share Issue in an Expected Amount of SEK 2.75 Billion [NOT FOR US, CA, et al.]". Gothenburg. 2021-03-11
Cellink AB. (3/10/21). "Press Release: Cellink Has Entered into an Agreement to Acquire MatTek, the Global Leader in In-vitro Technology and Alternative Drug Testing Models". 2021-03-10
AgomAb Therapeutics N.V.. (3/10/21). "Press Release: AgomAb Therapeutics Raises $74 Million Series B to Advance Regenerative Pathway Modulators". Ghent. 2021-03-10
BellaSeno GmbH. (3/10/21). "Press Release: BellaSeno and Fraunhofer Institute for Production Technology IPT Receive EUR 1.4 Million BMBF Grant". Leipzig & Aachen. 2021-03-10
BioPhero ApS. (3/9/21). "Press Release: BioPhero Announces $17 Million Series A For Sustainable Pest Control". Copenhagen. 2021-03-09
Ventyx Biosciences, Inc.. (3/9/21). "Press Release: Ventyx Biosciences Raises $114 Million Financing Led by VenBio Partners to Advance Diverse Pipeline of Immunology Programs". Encinitas, CA. 2021-03-09
Pathios Therapeutics Ltd.. (3/8/21). "Press Release: Pathios Therapeutics Boosted by Award of Significant Innovate UK Funding". Oxford. 2021-03-08
Mikrogen GmbH. (3/8/21). "Press Release: Mikrogen Acquires Lophius Biosciences to Expand into T Cell-Based Testing Market". Neuried & Regensburg. 2021-03-08
Exscientia Ltd.. (3/4/21). "Press Release: Exscientia Completes $100 Million Series C Financing Round with BlackRock Funds". 2021-03-04
Sofinnova Partners. (3/3/21). "Press Release: Sofinnova Partners Closes €445M ($540M) Oversubscribed Late-stage Healthcare Crossover Fund". Paris. 2021-03-03
Atai Life Sciences AG. (3/3/21). "Press Release: Atai Life Sciences Announces the Closing of Its $157 Million Series D Financing Round". New York, NY. 2021-03-03
Osborne Clarke. (3/2/21). "Press Release: Osborne Clarke Advises Oxular on Its £27M Financing". 2021-03-02
Oxford Genetics Ltd.. (3/2/21). "Press Release: WuXi AppTec Completes Acquisition of Oxgene to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers". Philadeliphia, PA & Oxford. 2021-03-02
ActiTrexx GmbH. (3/2/21). "Press Release: Newly Founded Biotech Company ActiTrexx Receives Funding of € 3.5 Million to Develop Cell Therapy against Transplant Rejection". Mainz. 2021-03-02
EG 427. (3/1/21). "Press Release: EG 427 Announces €12 Million Series A Financing to Advance Its HSV-1 based Gene Therapy David Lamond and Stephane Boissel join the company’s board of Directors". Paris. 2021-03-01
Cellink AB. (3/1/21). "Press Release: Cellink Completes the Acquisition of Ginolis Oy". 2021-03-01
Achilles Therapeutics plc. (3/1/21). "Press Release: Achilles Therapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering in the United States". London. 2021-03-01
Oxular Ltd.. (3/1/21). "Press Release: Oxular Raises $37 Million". Oxford. 2021-03-01
Hologic, Inc.. (3/1/21). "Press Release: Hologic Acquires European Molecular Diagnostic Company Diagenode for Approximately $159 Million". Marlborough, MA. 2021-03-01
Roivant Sciences GmbH. (2/26/21). "Press Release: Roivant Grows Computational Drug Discovery Engine with Acquisition of Silicon Therapeutics". New York, NY, Boston, MA & Basel. 2021-02-26
Osborne Clarke. (2/25/21). "Press Release: Osborne Clarke Advised Delphi Genetics on Its Acquisition by Catalent". 2021-02-25
10x Genomics Inc.. (2/24/21). "Press Release: 10x Genomics Showcases Next Wave of Innovations at First Ever Xperience Event. Acquires Tetramer Shop, Reveals Details on Upcoming Products". Pleasanton, CA. 2021-02-24
Vividion Therapeutics, Inc.. (2/24/21). "Press Release: Vividion Announces $135 Million Series C Financing to Fuel Broad Pipeline of Precision Oncology and Immunology Programs". San Diego, CA. 2021-02-24
Catalent. (2/23/21). "Press Release: Catalent to Acquire Delphi Genetics and Launch US Plasmid Manufacturing Site to Establish Global pDNA Development and Manufacturing Capabilities". Somerset, NJ & Gosselies. 2021-02-23
Mosa Meat B.V.. (2/23/21). "Press Release: Mosa Meat Completes $85m Series B Investment Round". Maastricht. 2021-02-23
Newcells Biotech Ltd.. (2/23/21). "Press Release: Newcells Biotech Secures Over £5m for 3D Tissue Models". 2021-02-23
Novo Holdings A/S. (2/22/21). "Press Release: Novo Holdings to Acquire Altasciences". Copenhagen. 2021-02-22
Teon Therapeutics. (2/22/21). "Press Release: Teon Therapeutics Completes $30 Million Series A Financing". San Francisco, CA. 2021-02-22
Evox Therapeutics Ltd.. (2/18/21). "Press Release: Evox Therapeutics Completes £69.2 Million Series C Financing". 2021-02-18
Charles River Laboratories International, Inc.. (2/17/21). "Press Release: Charles River Laboratories to Acquire Cognate BioServices to Create a Premier Scientific Partner for Cell and Gene Therapy Development". Wilmington, MA. 2021-02-17
Cellink AB. (2/15/21). "Press Release: Cellink Has Entered into an Agreement to Acquire the Advanced Robotics and Diagnostics Automation Company Ginolis". 2021-02-15
EnginZyme AB. (2/11/21). "Press Release: EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden". Stockholm. 2021-02-11
Immunai. (2/11/21). "Press Release: Immunai Raises $60M to Reprogram Immunity". New York, NY. 2021-02-11
Forbion Capital Partners. (2/10/21). "Press Release: Launch of Novel Gene Therapy Company, VectorY, to Develop Innovative Vectorized Antibodies". Amsterdam. 2021-02-10
Evaxion Biotech A/S. (2/10/21). "Press Release: Evaxion Biotech Closes Its U.S. Initial Public Offering of American Depositary Shares". Copenhagen. 2021-02-10
SpyBiotech Ltd.. (2/10/21). "Press Release: SpyBiotech Raises $32.5M in Series A funding and Appoints Lutz B. Giebel as Chairman". Oxford. 2021-02-10
Pan Cancer T B.V.. (2/8/21). "Press Release: Onco-immunology Company Pan Cancer T Launched as Spin-off from Erasmus Medical Center". 2021-02-08
V-Bio Ventures. (2/4/21). "Press Release: First Closing of V-Bio Fund 2 Is Announced at EUR 78 Million". Ghent. 2021-02-04
Evaxion Biotech A/S. (2/4/21). "Press Release: Evaxion Biotech Announces Pricing of Initial Public Offering". Copenhagen. 2021-02-04
Scienion AG. (2/3/21). "Press Release: Scienion Continues to Grow and Will Build New Headquarters in Berlin Adlershof". Berlin. 2021-02-03
Abingworth LLP. (2/3/21). "Press Release: Abingworth Raises $465m for New Life Sciences Fund Abingworth Bioventures 8". London. 2021-02-03
Jazz Pharmaceuticals plc. (2/3/21). "Press Release: Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader". Dublin & London. 2021-02-03
Wacker Chemie AG. (2/3/21). "Press Release: Wacker Strengthens Biologics Business by Acquiring US-based Plasmid DNA Manufacturer Genopis". Munich & San Diego, CA. 2021-02-03
Cytiva. (2/1/21). "Press Release: Cytiva Acquires Vanrx Pharmasystems, Canadian Aseptic Filling Innovator". Amersham. 2021-02-01
Aber Instruments. (2/1/21). "Press Release: Aber Instruments Acquires BugLab to Consolidate its World-leading Biomass Monitoring Portfolio". Alexandria, VA. 2021-02-01
BiondVax Pharmaceuticals Ltd.. (1/29/21). "Press Release: BiondVax Announces Pricing of $12.1 Million Follow-on Underwritten Offering of American Depositary Shares". Jerusalem. 2021-01-29
BiondVax Pharmaceuticals Ltd.. (1/28/21). "Press Release: BiondVax Announces Launch of Proposed Underwritten Follow-on Offering of American Depositary Shares". Jerusalem. 2021-01-28
Enthera S.r.l.. (1/28/21). "Press Release: Enthera Pharmaceuticals Extends Series A Financing, Raising a Total of €35 million". Milan. 2021-01-28
CureVac N.V.. (1/28/21). "Press Release: CureVac Announces Pricing of $450 million Follow-on Public Offering of Common Shares". Tübingen & Boston, MA. 2021-01-28
High-Tech Gründerfonds Management GmbH. (1/26/21). "Press Release: GeneQuine Biotherapeutics Secures more than €9 Million in Series A Financing and Non-Dilutive Funding to Advance Gene Therapy Pipeline for Musculoskeletal Diseases". 2021-01-26
Microcaps AG. (1/26/21). "Press Release: Microcaps Closes CHF 5 Million Seed Financing Round Co-led by Helvetica Capital and Zürcher Kantonalbank". Zurich. 2021-01-26
Cellvie Inc.. (1/25/21). "Press Release: Harvard Spin-off Cellvie Closes $5M Seed Round in Pursuit of a New Treatment Modality – Therapeutic Mitochondria Transfer". Zurich & Houston, TX. 2021-01-25
TScan Therapeutics Inc.. (1/25/21). "Press Release: TScan Therapeutics Announces $100 Million Series C Financing". Waltham, MA. 2021-01-25
Omnix Medical. (1/25/21). "Press Release: Omnix Medical Wins €10.8M in EIC Accelerator Funding". 2021-01-25
CureVac N.V.. (1/25/21). "Press Release: CureVac Announces Proposed Public Offering of Common Shares". Tübingen & Boston, MA. 2021-01-25
Merus N.V.. (1/21/21). "Press Release: Merus Announces Pricing of Public Offering of Common Shares". Utrecht & Cambridge, MA. 2021-01-21
Relief Therapeutics Holding AG. (1/20/21). "Press Release: Relief and AdVita Sign Binding Term Sheet for Relief to Acquire All Shares of AdVita to Expand Scope of Development of Inhaled Formulation of Aviptadil". Geneva & Gundelfingen. 2021-01-20
Life Sciences Partners (LSP). (1/20/21). "Press Release: LSP Leads EUR 21 Million Series B Funding Round in Neurent Medical". Amsterdam. 2021-01-20
Biophytis S.A.. (1/20/21). "Press Release: Biophytis Announces Public Filing of a Registration Statement for Proposed Initial Public Offering in the United States". Paris & Cambridge, MA. 2021-01-20
Slate Bio, Inc.. (1/19/21). "Press Release: Slate Bio Launches with Seed Financing to Develop Next Generation IL-2 Therapies". Charlottesville, VA. 2021-01-19
Merus N.V.. (1/19/21). "Press Release: Merus N.V. Announces Proposed Public Offering of Common Shares". Utrecht & Cambridge, MA. 2021-01-19
Forbion Capital Partners. (1/19/21). "Press Release: Forbion Invests USD 2.3M in Seed Financing of CoviCept Therapeutics, Inc.". Naarden. 2021-01-19
High-Tech Gründerfonds Management GmbH. (1/18/21). "Press Release: LignoPure Secures € 2.2 Million Seed Round with High-Tech Gründerfonds, Innovationsstarter Fonds Hamburg GmbH (IFH) and Swiss Holding Tanovis AG". 2021-01-18
Thermo Fisher Scientific Inc.. (1/15/21). "Press Release: Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep". Waltham, MA & Lyon. 2021-01-15
Affimed N.V.. (1/15/21). "Press Release: Affimed Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares". Heidelberg. 2021-01-15
Cognate Bioservices, Inc.. (1/14/21). "Press Release: Cognate BioServices Announces Major Expansion of Manufacturing Facilities in US and Europe". Memphis, TN. 2021-01-14
NewAmsterdam Pharma B.V.. (1/14/21). "Press Release: NewAmsterdam Pharma Completes $196M (€160M) Series A Funding for Comprehensive Phase 3 Development Program". Naarden. 2021-01-14
UCB S.A.. (1/13/21). "Press Release: UCB Announces Launch of Nile AI, Inc., a Digital Health Company Set to Transform the Course of Epilepsy". Brussels & Atlanta, GA. 2021-01-13
IO Biotech ApS. (1/13/21). "Press Release: IO Biotech Completes Oversubscribed EUR 127 Million Series B Financing to Accelerate Clinical Programs in Oncology". Copenhagen. 2021-01-13
Affimed N.V.. (1/12/21). "Press Release: Affimed Announces Pricing of $100,000,000 Public Offering of Common Shares". Heidelberg. 2021-01-12
AltPep Corproration. (1/12/21). "Press Release: AltPep Corporation Closes Series A Financing". Seattle, WA. 2021-01-12
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25  next pagenext page



Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture Berlin Partner Bionnale 2021 Digital Event 650x80px

» top